Although fractures normally heal, bone will not regenerate under several circumstances. When bone does not regenerate, major clinical problems could result, including…
admin
-
-
Summary : FabiSpray will be marketed at a price of Rs 850 per unit. The recommended dosage for treatment of mild Covid-19…
-
Summary : SOLOSEC® demonstrated a 92.2% clinically and statistically significant cure rate for patients with trichomoniasis based on a landmark Phase 3…
-
Synopsis : Star Therapeutics has exited stealth mode and announced a spin-off company, Electra Therapeutics. Electra received $84 million in Series B…
-
Summary : The U.S. Food and Drug Administration has accepted Mirati Therapeutics’ New Drug Application (NDA) for its candidate drug for non-small cell lung cancer (NSCLC). The…
-
Global Market
Western Potash Holdings Corp. and Vantage Chance Limited Enter Into Subscription Agreement
by adminby adminSummary : Western Resources Corp. is pleased to announce that it has signed a subscription agreement (the “Subscription Agreement”) today with Vantage…
-
Pharma Science & Research
Marker Therapeutics Announces Clinical Program Updates and Pipeline Expansion
by adminby adminSummary : -Results from safety lead-in stage of Marker’s Phase 2 AML trial demonstrate that MT-401 was well-tolerated, eliminated measurable residual disease…
-
Global Market
VivoPower International PLC’s Kenshaw Critical Power Business Expands to New Headquarters
by adminby adminSummary : VivoPower International PLC (NASDAQ: VVPR) (“VivoPower,” the “Company”) is pleased to announce that its wholly-owned subsidiary in Australia, Kenshaw Electrical…
-
CompaniesPfizer
Lawsuit over Pfizer’s disclosures before Chantix recall is dismissed
by adminby adminSummary : A federal judge on Wednesday dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc of failing to…
-
Covid DrugsGlobal Market
Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed
by adminby adminSummary : A study in monkeys pitting the current Moderna Inc (MRNA.O) COVID-19 booster against an Omicron-specific booster showed no significant differences…
